AzTrials
AzTrials

ExophthalmometryHERTEL-MXNCT07705061

Hertel Exophthalmometry Values in Mexican Adults

An observational study of Exophthalmometry and Normal Exophthalmometric Values, run by Instituto de Oftalmología Fundación Conde de Valenciana at 1 site in Mexico.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Proptosis assessment using Hertel exophthalmometry is an essential part of the ophthalmic examination, but normal reference values vary among different populations. This observational study aims to establish normative Hertel exophthalmometry values in Mexican adults and to evaluate their association with demographic… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Hertel Exophthalmometry
How many people
300 participants
Where
1 siteMexico
Study dates
21 Apr 2026to 28 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Adult Mexican participants (≥18 years) recruited from the Ophthalmology Department who meet the eligibility criteria. Participants with and without systemic diseases will be included to establish normative Hertel exophthalmometry values and evaluate their association with demographic characteristics and systemic conditions.

Who may be able to join

  • Adults aged 18 years or older.
  • Mexican participants or individuals who self-identify as Mexican.
  • Ability to understand the study procedures and provide written informed consent.
  • Ability to undergo bilateral Hertel exophthalmometry.
  • Participants with or without previously diagnosed systemic diseases.

Who cannot join

  • Active thyroid eye disease
  • History of orbital trauma or orbital fracture.
  • Previous orbital surgery, orbital decompression, or surgery that may alter globe position.
  • Presence or history of an orbital tumor, orbital inflammation, or orbital infection.
  • Craniofacial abnormalities or facial asymmetry that may interfere with Hertel exophthalmometry.
  • Ocular or eyelid conditions that prevent accurate positioning or measurement with the Hertel exophthalmometer.
  • Inability to cooperate with the examination or obtain a reliable exophthalmometry measurement.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Roberto Ramirez Hernandez, MD, Ophthalmologist contact

+525525137712

robert.rami.rr@gmail.com

Mexico1 site, 1 recruiting
  • ✔ Instituto de Oftalmología Fundación Conde de Valenciana IAP

    Mexico City, Mexico City, 94806

    Roberto Ramirez Hernandez, 5525137712, robert.rami.rr@gmail.com

    Recruiting

Other trials in Mexico

About this study

Official title: Hertel Exophthalmometry Values in Mexican Adults and Their Association With Demographic Factors and Systemic Diseases

Proptosis assessment using Hertel exophthalmometry is an essential part of the ophthalmic examination, but normal reference values vary among different populations. This observational study aims to establish normative Hertel exophthalmometry values in Mexican adults and to evaluate their association with demographic characteristics (such as age and sex) and systemic diseases. Healthy adult participants and adults with selected systemic conditions will undergo standardized Hertel exophthalmometry measurements. The findings are expected to provide population-specific reference values that may improve the clinical assessment of orbital diseases in the Mexican population.

Read the detailed description

Background: Hertel exophthalmometry is the most commonly used method for measuring globe protrusion in clinical practice. Normal exophthalmometric values vary according to ethnicity, sex, age, and craniofacial anatomy; therefore, population-specific reference values are necessary for accurate clinical interpretation. Currently, normative data for Mexican adults are limited.

Objective: To establish normative Hertel exophthalmometry values in Mexican adults and to evaluate their association with demographic characteristics and systemic diseases.

Methods: This is a prospective observational study. Adult participants attending the Ophthalmology Department will be consecutively recruited after providing written informed consent. Hertel exophthalmometry measurements will be obtained using a standardized technique by trained examiners. Demographic information, including age and sex, as well as relevant medical history and systemic diseases, will be recorded. The primary outcome is the distribution of Hertel exophthalmometry values in the study population. Secondary analyses will assess associations between exophthalmometric measurements and demographic or systemic variables.

Expected Significance: The study will provide normative Hertel exophthalmometry values for the Mexican adult population and identify factors associated with physiological variations in globe protrusion. These findings may improve the clinical evaluation of patients with suspected orbital disease and facilitate interpretation of Hertel exophthalmometry measurements in routine ophthalmic practice.

Being tested
Hertel Exophthalmometry
Keywords
Hertel Exophthalmometry, Exophthalmometry, Mexican Adults, Orbital Anatomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hertel ExophthalmometryDiagnostic test

    Standardized bilateral Hertel exophthalmometry performed using a Hertel exophthalmometer to measure globe protrusion.

Study groups in NCT07705061
Study groupRoleWhat they receive
Mexican Adult ParticipantsAdult Mexican participants undergoing standardized Hertel exophthalmometry and collection of demographic and medical history information for the establishment of normative exophthalmometric values and evaluation of associated factors.
Receives: Diagnostic Test: Hertel Exophthalmometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hertel Exophthalmometry Value

    Bilateral Hertel exophthalmometry measurements (millimeters) obtained using a standardized Hertel exophthalmometer. Normative values will be estimated and summarized for the study population.

    Measured: At baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2026
  2. Study start21 Apr 2026
  3. Primary completion28 Dec 2026 (estimated)
  4. Study completion28 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07705061
Sponsor's protocol ID
HERTEL-MX-2026-01
Acronym
HERTEL-MX
Status last verified
Jul 2026
First submitted
10 Jul 2026
Last updated
15 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Exophthalmometry and Normal Exophthalmometric Values, run by Instituto de Oftalmología Fundación Conde de Valenciana at 1 site in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Roberto Ramirez Hernandez, MD, Ophthalmologist (+525525137712, robert.rami.rr@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hertel Exophthalmometry Value (time frame: At baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in